Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.

Rheinbay E, Suvà ML, Gillespie SM, Wakimoto H, Patel AP, Shahid M, Oksuz O, Rabkin SD, Martuza RL, Rivera MN, Louis DN, Kasif S, Chi AS, Bernstein BE.

Cell Rep. 2013 May 30;3(5):1567-79. doi: 10.1016/j.celrep.2013.04.021. Epub 2013 May 23.

2.

Wnt activation promotes neuronal differentiation of glioblastoma.

Rampazzo E, Persano L, Pistollato F, Moro E, Frasson C, Porazzi P, Della Puppa A, Bresolin S, Battilana G, Indraccolo S, Te Kronnie G, Argenton F, Tiso N, Basso G.

Cell Death Dis. 2013 Feb 21;4:e500. doi: 10.1038/cddis.2013.32. Erratum in: Cell Death Dis. 2013;4:e597.

3.

Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.

Wu Y, Richard JP, Wang SD, Rath P, Laterra J, Xia S.

Cancer Sci. 2012 Jun;103(6):1028-37. doi: 10.1111/j.1349-7006.2012.02260.x. Epub 2012 Apr 4.

4.

Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, Joo KM, Lee J, Nam DH.

Neuro Oncol. 2013 Feb;15(2):161-71. doi: 10.1093/neuonc/nos299. Epub 2012 Dec 20.

5.
6.

Brief report: Oct4 and canonical Wnt signaling regulate the cardiac lineage factor Mesp1 through a Tcf/Lef-Oct4 composite element.

Li Y, Yu W, Cooney AJ, Schwartz RJ, Liu Y.

Stem Cells. 2013 Jun;31(6):1213-7. doi: 10.1002/stem.1362.

7.

Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.

Suvà ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, Curry WT, Martuza RL, Rivera MN, Rossetti N, Kasif S, Beik S, Kadri S, Tirosh I, Wortman I, Shalek AK, Rozenblatt-Rosen O, Regev A, Louis DN, Bernstein BE.

Cell. 2014 Apr 24;157(3):580-94. doi: 10.1016/j.cell.2014.02.030. Epub 2014 Apr 10.

8.

AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.

Xia Z, Wei P, Zhang H, Ding Z, Yang L, Huang Z, Zhang N.

Mol Cancer Res. 2013 Sep;11(9):1101-11. doi: 10.1158/1541-7786.MCR-13-0044. Epub 2013 Jun 12.

9.

Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.

Wang B, Liu J, Ma LN, Xiao HL, Wang YZ, Li Y, Wang Z, Fan L, Lan C, Yang M, Hu L, Wei Y, Bian XW, Chen D, Wang J.

J Gastroenterol. 2013 Jul;48(7):798-808. doi: 10.1007/s00535-012-0711-z. Epub 2012 Nov 28.

PMID:
23188090
10.

Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.

Berezovsky AD, Poisson LM, Cherba D, Webb CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM, Mikkelsen T, deCarvalho AC.

Neoplasia. 2014 Mar;16(3):193-206, 206.e19-25. doi: 10.1016/j.neo.2014.03.006. Epub 2014 Apr 13.

11.

Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression.

Ahn SM, Byun K, Kim D, Lee K, Yoo JS, Kim SU, Jho EH, Simpson RJ, Lee B.

PLoS One. 2008;3(12):e3917. doi: 10.1371/journal.pone.0003917. Epub 2008 Dec 18.

12.

β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.

Zhou AD, Diao LT, Xu H, Xiao ZD, Li JH, Zhou H, Qu LH.

Oncogene. 2012 Jun 14;31(24):2968-78. doi: 10.1038/onc.2011.461. Epub 2011 Oct 24.

PMID:
22020335
13.

Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo.

Tanaka SS, Kojima Y, Yamaguchi YL, Nishinakamura R, Tam PP.

Dev Growth Differ. 2011 Sep;53(7):843-56. doi: 10.1111/j.1440-169X.2011.01292.x. Epub 2011 Jul 15. Review.

PMID:
21762130
14.

Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.

Kaur N, Chettiar S, Rathod S, Rath P, Muzumdar D, Shaikh ML, Shiras A.

Mol Cell Neurosci. 2013 May;54:44-57. doi: 10.1016/j.mcn.2013.01.001. Epub 2013 Jan 19.

PMID:
23337036
15.

Ascl1/Mash1 is a novel target of Gli2 during Gli2-induced neurogenesis in P19 EC cells.

Voronova A, Fischer A, Ryan T, Al Madhoun A, Skerjanc IS.

PLoS One. 2011 Apr 29;6(4):e19174. doi: 10.1371/journal.pone.0019174.

16.

A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis.

Petropoulos K, Arseni N, Schessl C, Stadler CR, Rawat VP, Deshpande AJ, Heilmeier B, Hiddemann W, Quintanilla-Martinez L, Bohlander SK, Feuring-Buske M, Buske C.

J Exp Med. 2008 Mar 17;205(3):515-22. doi: 10.1084/jem.20071875. Epub 2008 Mar 3.

17.

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

Gatti M, Pattarozzi A, Bajetto A, Würth R, Daga A, Fiaschi P, Zona G, Florio T, Barbieri F.

Toxicology. 2013 Dec 15;314(2-3):209-20. doi: 10.1016/j.tox.2013.10.003. Epub 2013 Oct 21.

PMID:
24157575
18.
19.

The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.

Cai C, Zhu X.

Mol Med Rep. 2012 May;5(5):1191-6. doi: 10.3892/mmr.2012.802. Epub 2012 Feb 21.

PMID:
22367735
20.

Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.

Sandberg CJ, Altschuler G, Jeong J, Strømme KK, Stangeland B, Murrell W, Grasmo-Wendler UH, Myklebost O, Helseth E, Vik-Mo EO, Hide W, Langmoen IA.

Exp Cell Res. 2013 Aug 15;319(14):2230-43. doi: 10.1016/j.yexcr.2013.06.004. Epub 2013 Jun 18.

Supplemental Content

Support Center